CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• EPS Cop. Y/Y Annual
Cardiff Lexington Corporation  (CDIF)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

CDIF's EPS from Cont. Operations Growth by Quarter and Year

Cardiff Lexington's EPS from Cont. Operations results by quarter and year




CDIF EPS from Cont. Operations (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December -0.10 4.99 -0.01 0.01
III Quarter September -0.16 0.00 0.00 0.01
II Quarter June -0.04 0.00 0.00 -0.02
I Quarter March -0.11 0.00 0.00 -0.03
FY   -0.41 4.99 -0.01 -0.03



CDIF EPS from Cont. Operations fourth quarter 2024 Y/Y Growth Comment
Cardiff Lexington Corporation in the fourth quarter 2024 recorded EPS loss from Cont. Operations of $ -0.10 .

According to the results reported in the fourth quarter 2024, Cardiff Lexington Corporation achieved the best EPS from Cont. Operations growth in Healthcare Facilities industry. While Cardiff Lexington Corporation' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2024.


CDIF EPS from Cont. Operations ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - - - -99.98 %
III Quarter September - - - -99.68 %
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cardiff Lexington's fourth quarter 2024 EPS from Cont. Operations $ -0.10 CDIF's Income Statement
Cardiff Lexington's fourth quarter 2023 EPS from Cont. Operations $ 4.99 Quarterly CDIF's Income Statement


CDIF EPS from Cont. Operations (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - - - 0 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -


Go to CDIF financial reports >> Back to CDIF Growth rate Comparisons >>


EPS from Cont. Operations fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Cardiff Lexington's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q EPS from Cont. Operations Comment
Even if Cardiff Lexington Corporation in the IV. Quarter 2024 revealed EPS loss from Cont. Operations of $ -0.10 , management said, that those numbers show improvement relative to the -0.16 in the third quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential EPS from Cont. Operations growth. While Cardiff Lexington's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q EPS from Cont. Operations Comment
Although Cardiff Lexington Corporation in the IV. Quarter 2024 revealed EPS loss from Cont. Operations of $ -0.10 , some analyst point out, that current results point to slight up side relative to the -0.16 in the third quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential EPS from Cont. Operations growth. While Cardiff Lexington's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Cardiff Lexington's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.41 $ 4.68 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #


Cumulative EPS from Cont. Operations growth Comment
Cardiff Lexington Corporation' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ 0 in the Dec 31 2024 period.
The results are getting worse as the cumulative EPS loss from Cont. Operations is getting bigger from $ 4.68 in TTM ending quarter Sep 30 2024 and $ for the twelve months ending in the quarter a year ago.

Cardiff Lexington Corporation achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Cardiff Lexington Corporation' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ 0 in the Dec 31 2024 period.
The situation is detiriorating as the cumulative EPS loss from Cont. Operations is getting bigger from $ 4.68 in TTM ending quarter Sep 30 2024 and $ for the twelve months ending in the quarter Dec 31 2023 Micaela Teixeira told.

Cardiff Lexington Corporation achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Healthcare Facilities Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
CDIF's EPS from Cont. Operations Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for CDIF's Competitors
EPS from Cont. Operations Growth for Cardiff Lexington's Suppliers
EPS from Cont. Operations Growth for CDIF's Customers

You may also want to know
CDIF's Annual Growth Rates CDIF's Profitability Ratios CDIF's Asset Turnover Ratio CDIF's Dividend Growth
CDIF's Roe CDIF's Valuation Ratios CDIF's Financial Strength Ratios CDIF's Dividend Payout Ratio
CDIF's Roa CDIF's Inventory Turnover Ratio CDIF's Growth Rates CDIF's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2024
Merit Medical Systems Inc-0.13%$ -0.133 
Integra Lifesciences Holdings Corp-0.25%$ -0.247 
Insulet Corporation-2.94%$ -2.941 
West Pharmaceutical Services Inc -3.27%$ -3.268 
Inmode Ltd -3.38%$ -3.376 
Corcept Therapeutics Inc-3.61%$ -3.610 
Hca Healthcare Inc -4.92%$ -4.916 
Iqvia Holdings Inc -5.21%$ -5.209 
Vertex Pharmaceuticals Inc-5.61%$ -5.613 
Johnson and Johnson-10.91%$ -10.911 
Progyny Inc -12.21%$ -12.207 
Align Technology inc -14.86%$ -14.858 
Hologic Inc-15.53%$ -15.534 
Profound Medical Corp -16.80%$ -16.802 
Alpha Pro Tech Ltd -16.97%$ -16.969 
Amgen Inc -18.50%$ -18.502 
Regeneron Pharmaceuticals Inc -21.74%$ -21.743 
National Research Corporation-22.22%$ -22.222 
Amphastar Pharmaceuticals Inc -26.55%$ -26.548 
Neurocrine Biosciences Inc -31.38%$ -31.384 
Entera Bio Ltd -33.54%$ -33.536 
Utah Medical Products Inc-36.11%$ -36.111 
Siga Technologies Inc-36.63%$ -36.634 
Penumbra Inc -37.52%$ -37.517 
Zimmer Biomet Holdings Inc -40.48%$ -40.480 
Dexcom Inc -41.84%$ -41.841 
Acadia Healthcare Company Inc -43.68%$ -43.682 
3m Company-43.79%$ -43.787 
Healthcare Services Group Inc -47.06%$ -47.063 
Stryker Corp-52.45%$ -52.452 


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com